ATLN Stock - Atlantic International Corp.
Unlock GoAI Insights for ATLN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $442.61M | $401.37M | $441.54M | $425.03M | $329,495 |
| Gross Profit | $47.18M | $46.88M | $54.21M | $54.41M | $158,692 |
| Gross Margin | 10.7% | 11.7% | 12.3% | 12.8% | 48.2% |
| Operating Income | $-21,834,592 | $-3,451,524 | $5.98M | $-35,730,314 | $-949,720 |
| Net Income | $-135,479,890 | $-15,252,020 | $-3,221,058 | $-40,798,298 | $-1,045,353 |
| Net Margin | -30.6% | -3.8% | -0.7% | -9.6% | -317.3% |
| EPS | $-3.68 | $-0.60 | $-0.19 | $-0.17 | $-0.05 |
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
Visit WebsiteEarnings History & Surprises
ATLNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 27, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | $-0.18 | $-0.20 | -11.1% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | — | $-0.20 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.20 | — | — |
Q1 2025 | Mar 28, 2025 | — | $-1.64 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.16 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.72 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-2.87 | — | — |
Q4 2023 | Dec 31, 2023 | $-3.60 | $-3.26 | +9.4% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $-5.20 | $-3.33 | +36.0% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $-5.20 | $-4.03 | +22.4% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | — | $-4.83 | — | — |
Q4 2022 | Dec 31, 2022 | $-3.20 | $-4.16 | -30.0% | ✗ MISS |
Q3 2022 | Sep 29, 2022 | $-3.60 | $-3.12 | +13.4% | ✓ BEAT |
Q2 2022 | Jun 29, 2022 | — | $-3.35 | — | — |
Q1 2022 | Mar 30, 2022 | — | $-3.16 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-4.70 | — | — |
Q3 2021 | Sep 29, 2021 | — | $-2.15 | — | — |
Latest News
Atlantic International Corp Files For Mixed Shelf Of Up To $250M
➖ NeutralAtlantic International Achieves Strong YTD Performance With $315.8M Service Revenue And $34.5M Net Loss Improvement Driven By Record Q3 And Efficiency Initiatives
📈 PositiveFrequently Asked Questions about ATLN
What is ATLN's current stock price?
What is the analyst price target for ATLN?
What sector is Atlantic International Corp. in?
What is ATLN's market cap?
Does ATLN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ATLN for comparison